Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Summary 
Currently, Barbara Gayle Duncan holds the position of Chairman of Fusion Pharmaceuticals, Inc.

She is also on the board of Atea Pharmaceuticals, Inc., Ovid Therapeutics, Inc., Jounce Therapeutics, Inc. and Adaptimmune Therapeutics Plc.

In the past Ms. Duncan was Chief Financial Officer, Secretary & Treasurer for Intercept Pharmaceuticals, Inc., Principal at PepsiCo, Inc., Chief Executive & Financial Officer, Director at DOV Pharmaceutical, Inc., Director-Corporate Finance at SBC Warburg Dillon Read Corporate Finance AG, Vice President-Corporate Finance Division at Lehman Brothers, Inc. and Principal at Deloitte & Touche LLP.

She received an undergraduate degree from Louisiana State University and an MBA from The Wharton School of the University of Pennsylvania.


Current positions of Barbara Gayle Duncan 
NameTitle Since
Atea Pharmaceuticals, Inc.
(Biotechnology & Medical Research)
Independent Director 2020
Adaptimmune Therapeutics plc
(Biotechnology & Medical Research)
Independent Non-Executive Director 2016
Fusion Pharmaceuticals Inc.
(Biotechnology & Medical Research)
Chairman 2020
Jounce Therapeutics, Inc.
(Biotechnology & Medical Research)
Independent Director 2016
Ovid Therapeutics Inc.
(Biotechnology & Medical Research)
Independent Director 2017


Holdings of Barbara Gayle Duncan 
NameEquities%Valuation
Adaptimmune Therapeutics Plc00.0000%0 USD
Ovid Therapeutics Inc. (OVID)
(Biotechnology & Medical Research)
00.0000%0 USD
Jounce Therapeutics, Inc. (JNCE)
(Biotechnology & Medical Research)
00.0000%0 USD
Atea Pharmaceuticals, Inc. (AVIR)
(Biotechnology & Medical Research)
00.0000%0 USD
Fusion Pharmaceuticals Inc. (FUSN)
(Biotechnology & Medical Research)
00.0000%0 USD


Barbara Gayle Duncan: Personal Network 
Most Read News 
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
RE
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
RE
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
09/08MICHAEL O'LEARY : Exclusive-Ryanair ready to wait years for Boeing to cut prices, says O'Leary
RE
09/07PATRICK DRAHI : Changes Expected at BT Following Drahi's Stake Buildup, Deutsche Telekom CEO Says -Bloomberg
DJ
More news


© 2021 People and Ownership :   
Barbara Gayle Duncan : Connections